Tactile Systems Technology, Inc. (TCMD)

Market Cap	315.81M
Revenue (ttm)	292.98M
Net Income (ttm)	16.96M
Shares Out	23.59M
EPS (ttm)	0.70
PE Ratio	19.27
Forward PE	19.99
Dividend	n/a
Ex-Dividend Date	n/a

Volume	120,779
Open	13.49
Previous Close	13.49
Day's Range	13.27 - 13.57
52-Week Range	11.12 - 21.10
Beta	1.24
Analysts	Hold
Price Target	18.00 (+34.43%)
Earnings Date	May 5, 2025

About TCMD

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Nimbl, a pneumatic compression platform for the trea...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 28, 2016
• Employees: 1,037
• Stock Exchange: NASDAQ
• Ticker Symbol: TCMD
• Website: https://tactilemedical.com

Financial Performance

In 2024, TCMD's revenue was $292.98 million, an increase of 6.76% compared to the previous year's $274.42 million. Earnings were $16.96 million, a decrease of -40.52%.

Analyst Forecast

According to 2 analysts, the average rating for TCMD stock is "Hold." The 12-month stock price forecast is $18.0, which is an increase of 34.43% from the latest price.

Price Target

$18.0

(34.43% upside)

Analyst Consensus: Hold